Bad blood: secrets and lies in a Silicon Valley startup
(Audio CD)

Book Cover
Contributors:
Published:
New York, NY : Random House Audio, p2018., New York, NY : Random House Audio, [2018].
Format:
Audio CD
Edition:
Unabridged.
Physical Desc:
9 audio discs (11 1/2 hr.) : digital ; 4 3/4 in.
Status:
Boulder Main Books on CD
D 338.7681761 Holmes
Copies
Location
Call Number
Status
Last Check-In
Boulder Main Books on CD
D 338.7681761 Holmes
On Shelf
Aug 2, 2023
Description

In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: the technology didn't work. For years, Holmes had been misleading investors, FDA officials, and her own employees. When the author, working at The Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both the author and the newspaper were threatened with lawsuits. Undaunted, the paper ran the first of dozens of Theranos articles in late 2015. By early 2017, the company's value was zero and Holmes faced potential legal action from the government and her investors. The biggest corporate fraud since Enron is a cautionary tale set amid the bold promises and gold-rush frenzy of Silicon Valley.--adapted from publisher's description.

Also in This Series
More Like This
Other Editions and Formats
More Copies In Prospector
Loading Prospector Copies...
More Details
Language:
English
ISBN:
9780593105061
UPC:
9780593105061

Notes

General Note
Title from container.
General Note
Compact discs.
Participants/Performers
Read by Will Damron.
Description
In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: the technology didn't work. For years, Holmes had been misleading investors, FDA officials, and her own employees. When the author, working at The Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both the author and the newspaper were threatened with lawsuits. Undaunted, the paper ran the first of dozens of Theranos articles in late 2015. By early 2017, the company's value was zero and Holmes faced potential legal action from the government and her investors. The biggest corporate fraud since Enron is a cautionary tale set amid the bold promises and gold-rush frenzy of Silicon Valley.--adapted from publisher's description.
Local note
BPL: some copies repackaged by Midwest Tape.
Reviews from GoodReads
Loading GoodReads Reviews.
Citations
APA Citation (style guide)

Carreyrou, J., & Damron, W. (2018). Bad blood: secrets and lies in a Silicon Valley startup. Unabridged. New York, NY, Random House Audio.

Chicago / Turabian - Author Date Citation (style guide)

Carreyrou, John and Will. Damron. 2018. Bad Blood: Secrets and Lies in a Silicon Valley Startup. New York, NY, Random House Audio.

Chicago / Turabian - Humanities Citation (style guide)

Carreyrou, John and Will. Damron, Bad Blood: Secrets and Lies in a Silicon Valley Startup. New York, NY, Random House Audio, 2018.

MLA Citation (style guide)

Carreyrou, John, and Will Damron. Bad Blood: Secrets and Lies in a Silicon Valley Startup. Unabridged. New York, NY, Random House Audio, 2018.

Note! Citation formats are based on standards as of July 2022. Citations contain only title, author, edition, publisher, and year published. Citations should be used as a guideline and should be double checked for accuracy.
Staff View
Grouped Work ID:
baef1559-c66a-350a-94da-a1c38154f67e
Go To GroupedWork

Record Information

Last Sierra Extract TimeMar 25, 2024 11:13:31 PM
Last File Modification TimeMar 25, 2024 11:13:40 PM
Last Grouped Work Modification TimeMar 28, 2024 11:58:40 AM

MARC Record

LEADER03463cim 22006134a 4500
0011084446517
003OCoLC
00520190426024211.0
007sd fmngnnmmned
008190123s2018    nyunnnn        z  n eng d
020 |a 9780593105061
0241 |a 9780593105061
02842|a PRHA 7990|b Penguin Random House Audio
035 |a (OCoLC)1084446517|z (OCoLC)1084401242
037 |a 60cjy8|b Blackstone Publishing
037 |a 40cjy8|b Blackstone Publishing
040 |a TOH|b eng|c TOH|d OCLCQ|d TEF|d BLACP|d GK8|d CoBoFLC
043 |a n-us---
050 4|a HD9995.H423|b U627 2018ab
08204|a 338.7/681761|2 23
1001 |a Carreyrou, John,|e author.
24510|a Bad blood|h [compact disc] :|b secrets and lies in a Silicon Valley startup /|c John Carreyrou.
24630|a Secrets and lies in a Silicon Valley startup
250 |a Unabridged.
260 |a New York, NY :|b Random House Audio,|c p2018.
264 1|a New York, NY :|b Random House Audio,|c [2018]
264 4|c ℗2018
300 |a 9 audio discs (11 1/2 hr.) :|b digital ;|c 4 3/4 in.
306 |a 113000
336 |a spoken word|b spw|2 rdacontent
337 |a audio|b s|2 rdamedia
338 |a audio disc|b sd|2 rdacarrier
340 |b 4 3/4 in.
344 |a digital|2 rdatr|0 http://rdaregistry.info/termList/typeRec/1002
344 |b optical|2 rdarm|0 http://rdaregistry.info/termList/recMedium/1003
344 |c 1.4 m/s
344 |g mono|2 rdapc|0 http://rdaregistry.info/termList/configPlayback/1001
344 |h digital recording
500 |a Title from container.
500 |a Compact discs.
5111 |a Read by Will Damron.
520 |a In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: the technology didn't work. For years, Holmes had been misleading investors, FDA officials, and her own employees. When the author, working at The Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both the author and the newspaper were threatened with lawsuits. Undaunted, the paper ran the first of dozens of Theranos articles in late 2015. By early 2017, the company's value was zero and Holmes faced potential legal action from the government and her investors. The biggest corporate fraud since Enron is a cautionary tale set amid the bold promises and gold-rush frenzy of Silicon Valley.--adapted from publisher's description.
590 |a BPL: some copies repackaged by Midwest Tape.
60010|a Holmes, Elizabeth,|d 1984-
61020|a Theranos (Firm)|x History.
650 0|a Hematologic equipment industry|z United States.
650 0|a New business enterprises|x Corrupt practices|z United States|v Case studies.
650 0|a Securities fraud|z United States|v Case studies.
655 7|a Sound recording.|2 local
655 7|a Audiobooks.|2 lcgft
7001 |a Damron, Will.
907 |a .b29007884|b bm
945 |y .i4433624x|i R0095558857|l bmbca|s -|h |u 21|x 2|w 0|v 10|t 19|z 190429|1 08-02-2023 18:10|o -|f D|a 338.7681761|b Holmes
998 |f -|e f |i eng|h bm